However, significant weight loss and metabolic improvements might take longer, often several months, with consistent use and alongside lifestyle modifications
10.1007/s10787-024-01603-y 17 De GiorgiR.GhenciulescuA.DziwiszO.TaquetM.AdlerA
Post-Cushing's patients in biochemical remission lose an average of 12.3% body weight on GLP-1 therapy over 48 weeks, compared to 4.1% with diet alone, per 2024 JCEM research
Dose adjustments may be necessary when taking semaglutide, depending on individual patient needs and responses to treatment
Most users report that side effects that were bothersome during weeks 1-4 become minimal or absent by weeks 8-12, even at higher maintenance doses
The official labeling lists nausea, vomiting, diarrhea, abdominal pain, and constipation among the most common adverse reactions